Skyscape Inc.

Call Directions Website

Up-to-the-minute clinical information & updates tailored for your profession & specialty. Real-time Secure Communication & Collaboration.
(1)

Over 1 million medical professionals trust Skyscape. Join our Community https://community.skyscape.com/home Over 350 Medical and Nursing resources for your mobile device.

10/23/2026

Meet the game-changer in CCM prep: 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗗𝗲𝗰𝗼𝗱𝗶𝗻𝗴.

Master your Certified Case Manager exam with 𝗖𝗖𝗠 𝗘𝘅𝗮𝗺 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗧𝗲𝘀𝘁 𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗯𝘆 𝗦𝗸𝘆𝘀𝗰𝗮𝗽𝗲, now updated with 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗗𝗲𝗰𝗼𝗱𝗶𝗻𝗴 to help you break down scenarios, identify key clues, eliminate distractors, and understand why each answer choice is right or wrong.

Build the 𝗰𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 you need to pass on your very first try.
‎
‎
📲 𝗚𝗲𝘁 𝗶𝘁 𝗼𝗻 𝘆𝗼𝘂𝗿 𝗽𝗵𝗼𝗻𝗲 ➡️ tap the 𝗹𝗶𝗻𝗸 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗰𝗼𝗺𝗺𝗲𝗻𝘁!
‎
‎

10/23/2026

Test your knowledge: answer this week’s

For the correct answer and rationale, see the link in the first comment

#‎nclex ‪ #‎nursing ‪ #‎nclexqowskyscape

10/23/2026

A single infusion of investigational CRISPR-based lonvoguran ziclumeran reduced monthly hereditary angioedema attacks by 87% compared with placebo in the phase 3 HAELO trial. Although the findings point to the potential of gene editing as a treatment strategy for this rare genetic disorder, longer follow-up is needed to establish durability and assess uncommon or delayed safety risks.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/pediatrics/13849/2026.10.23.01/single-dose-crispr-gene-editing-reduces-hereditary-angioedema-attacks-by-87

10/22/2026

The STRONG-DM pilot study of 545 adults found that combining NT-proBNP screening, EHR decision support, and virtual specialist consultations tripled the initiation of heart failure prevention therapies (IRR, 3.03; P < .001). NT-proBNP testing also identified 16.7% more high-risk patients missed by WATCH-DM scores alone, supporting the feasibility of biomarker-guided prevention in primary care.

𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/endocrinology/13848/2026.10.22.01/nt-probnp-guided-screening-increases-uptake-of-heart-failure-prevention-therapies-in-type-2-diabetes

10/21/2026

📚 𝗔𝘀𝘀𝗲𝘀𝘀 𝗪𝗶𝘁𝗵 𝗖𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝗰𝗲 𝗔𝗰𝗿𝗼𝘀𝘀 𝗔𝗹𝗹 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀

Get streamlined, step-by-step guidance with 𝗡𝘂𝗿𝘀𝗲𝘀' 𝗛𝗮𝗻𝗱𝗯𝗼𝗼𝗸 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁, including normal and abnormal findings plus pediatric, geriatric, and cultural variations.

📲 𝗚𝗲𝘁 𝗶𝘁 𝗼𝗻 𝘆𝗼𝘂𝗿 𝗽𝗵𝗼𝗻𝗲 ➡️ tap the 𝗹𝗶𝗻𝗸 𝗶𝗻 𝗯𝗶𝗼 or 𝗳𝗶𝗿𝘀𝘁 𝗰𝗼𝗺𝗺𝗲𝗻𝘁!

10/21/2026

Lean body weight does not necessarily mean lower risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). In a US hospitalization-based analysis, lean MASLD was associated with higher odds of mortality, hepatic complications, and several gastrointestinal malignancies compared with nonlean MASLD. Although the observational findings cannot establish causality, they highlight the importance of assessing disease severity rather than relying on BMI alone.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/gastroenterology/13847/2026.10.21.01/lean-masld-associated-with-higher-in-hospital-mortality-and-hepatic-complications

10/20/2026

A two-year cohort study evaluating 130 plasma biomarkers in 197 early Alzheimer’s patients on lecanemab identified significant, divergent shifts across 34 markers. While markers like p-tau217, MAPT, and GFAP partially normalized toward healthy levels, amyloid-beta showed overcorrection, and others (NPTXR, NRGN, TREM2) moved farther from baseline norms. These findings show that amyloid clearance produces complex, pathway-specific responses rather than uniform normalization, underscoring the potential for plasma biomarkers in monitoring therapy once further validated.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/neurology/13846/2026.10.20.01/lecanemab-treatment-produces-divergent-changes-in-plasma-biomarkers-of-alzheimers-disease

10/19/2026

The CDC reported 4,410 confirmed measles cases in the United States as of October 15, 2026 - nearly twice the total for all of 2025. With 96% of cases associated with outbreaks and kindergarten MMR coverage down to 92.4%, the resurgence highlights the consequences of gaps in community immunity. Early recognition, appropriate infection-control precautions, and maintaining vaccination coverage remain critical to preventing further spread.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/pediatrics/13845/2026.10.19.01/measles-cases-surge-in-the-united-states-4410-confirmed-cases-reported-in-2026

10/16/2026

A prospective trial of 597 pediatric patients undergoing elective gastrointestinal surgery found that while implementing enhanced recovery protocols (ERPs) did not reduce overall hospital length of stay, high protocol adherence delivered substantial clinical benefits. Patients receiving at least 13 of the 21 ERP elements experienced a 1.14-day shorter median hospital stay and a 52% reduction in postoperative complication odds (OR, 0.48), emphasizing that surgical recovery gains depend directly on consistent protocol ex*****on rather than adoption alone.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/pediatrics/13844/2026.10.16.01/enhanced-recovery-protocols-may-improve-outcomes-after-pediatric-gastrointestinal-surgery-when-adherence-is-high

10/15/2026

A prospective multicenter clinical practice study of 1,541 children and adolescents found that diversified segmental defocus optimization (DSDO) lenses resulted in lower axial elongation than DIMS lenses at 12 months (0.17 mm vs. 0.19 mm), with greater benefits observed in children aged 10 years or younger and those with low myopia. Additionally, among nonmyopic participants, DSDO lenses significantly limited 12-month axial growth compared with untreated controls (0.18 mm vs. 0.29 mm), supporting the potential of individualized optical strategies for both myopia control and prevention.

📎 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗠𝗲𝗱𝗕𝗲𝗮𝘁𝘀 𝘂𝗽𝗱𝗮𝘁𝗲:

https://medbeats.skyscape.com/ophthalmology/13843/2026.10.15.01/diversified-segmental-defocus-optimization-lenses-may-improve-myopia-control-in-children

Address

11 Apex Drive, Suite 300A
Marlborough, MA
01752

Telephone

+15082993000

Website

http://www.skyscape.com/

Alerts

Be the first to know and let us send you an email when Skyscape Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed health & beauty business in Marlborough?

Skyscape Inc.

10/23/2026

10/23/2026

10/23/2026

10/22/2026

10/21/2026

10/21/2026

10/20/2026

10/19/2026

10/16/2026

10/15/2026

Address

Telephone

Website

Alerts

Shortcuts

Share

Category

Listing takedown request